Skip to main content
FinSpry Logo
FinSpry
PYXS logo
PYXS
(NASDAQ)
Pyxis Oncology, Inc.
$2.23-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Pyxis Oncology (PYXS) Stock Price & Financial Analysis

Pyxis Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.12 - $2.30
52-Week High$5.55
52-Week Low$0.97
Open$2.19
Volume666.18K
Average Volume (3M)541.80K
Market Cap141.54M
Shares Outstanding63.47M
Price to Sales (P/S)10.21
Price to Book (P/B)4.53
EV/EBITDA-1.93
Revenue (TTM)13.86M
Net Income (TTM)-81.73M
Free Cash Flow (TTM)-66.98M
EPS (TTM)$-1.31
Profit Margin-589.80%
Operating Margin-619.61%
Return on Equity (ROE)-261.40%
Debt to Equity0.58
50-Day MA$1.92
200-Day MA$2.30
52-Week Change74.22%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Pyxis Oncology

What is the current stock price for PYXS?

As of the latest trading session, PYXS stock trades at $2.23. The 52-week range is $0.97–$5.55, with a day range of $2.12–$2.30.

What is the P/E ratio for PYXS?

The P/E ratio (Price-to-Earnings) for PYXS is shown in the Key Statistics section. This valuation metric helps compare Pyxis Oncology, Inc. to industry peers.

Does PYXS pay dividends?

Pyxis Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PYXS?

Based on 7 analysts, the consensus for PYXS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PYXS?

Pyxis Oncology's market capitalization is $141.5M, classifying it as a micro-cap company. Pyxis Oncology operates in the Healthcare sector within the Biotechnology industry.